Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-Methyldopa for climacteric hot flushes. A double-blind, randomized, cross-over study.

O Andersen, T Engebretsen, V M Solberg

    Acta Obstetricia Et Gynecologica Scandinavica
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocol.

    Basic & clinical pharmacology & toxicology·2023
    Same author

    Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis.

    Multiple sclerosis and related disorders·2022
    Same author

    Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation cohort.

    Multiple sclerosis journal - experimental, translational and clinical·2022
    Same author

    Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis.

    European journal of neurology·2020
    Same author

    Significance of progesterone receptors (PR-A and PR-B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study.

    BJOG : an international journal of obstetrics and gynaecology·2018
    Same author

    Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.

    Acta neurologica Scandinavica·2018
    Same journal

    Externally validated risk prediction models for gestational diabetes mellitus: A systematic review and meta-analysis.

    Acta obstetricia et gynecologica Scandinavica·2026
    Same journal

    Prenatal exome sequencing of fetuses with central nervous system anomalies based on prenatal ultrasound and magnetic resonance imaging diagnosis: A retrospective cohort study with a systematic review and meta-analysis.

    Acta obstetricia et gynecologica Scandinavica·2026
    Same journal

    Active surveillance of cervical intraepithelial neoplasia and adverse pregnancy outcomes: A register-based cohort study.

    Acta obstetricia et gynecologica Scandinavica·2026
    Same journal

    Commentary on central sensitization in chronic pelvic pain.

    Acta obstetricia et gynecologica Scandinavica·2026
    Same journal

    Clinicopathological phenotypes of singleton stillbirth: A retrospective cohort study.

    Acta obstetricia et gynecologica Scandinavica·2026
    Same journal

    Human papillomavirus persistence and clearance in women living with HIV: A five-year retrospective analysis from an Italian university center.

    Acta obstetricia et gynecologica Scandinavica·2026
    See all related articles

    Single evening doses of alpha-methyldopa may effectively reduce the severity of menopausal hot flushes. While patient preference favored alpha-methyldopa, further research is needed to confirm its efficacy compared to other regimens.

    Area of Science:

    • Obstetrics and Gynecology
    • Pharmacology

    Background:

    • Menopausal hot flushes are a common symptom affecting many women.
    • Existing treatments for hot flushes have varying efficacy and side effect profiles.

    Purpose of the Study:

    • To evaluate the efficacy of single evening doses of alpha-methyldopa in managing climacteric hot flushes.
    • To compare patient preference for alpha-methyldopa versus placebo.

    Main Methods:

    • A double-blind, randomized, cross-over study was conducted.
    • 40 women experiencing climacteric hot flushes participated.
    • 24 participants completed the study, assessing treatment preference, hot flush severity, and frequency.

    Main Results:

    • 15 out of 24 completers preferred alpha-methyldopa (p > 0.05).

    Related Experiment Videos

  • Alpha-methyldopa significantly reduced hot flush severity (p < 0.05).
  • No significant difference was found in hot flush frequency (p > 0.05).

    • Conclusions:

    • Single evening doses of alpha-methyldopa show potential efficacy in treating climacteric hot flushes, particularly in reducing severity.
    • Further investigation is warranted to compare this dosage regimen with twice-daily administration for optimal treatment outcomes.